EMERALD ADVISERS, LLC – Ultragenyx Pharmaceutical Inc. Transaction History
EMERALD ADVISERS, LLC portfolio value:
$14.37M
portfolio value
EMERALD ADVISERS, LLC quarter portfolio value change:
-30.59%
quarter
Ultragenyx Pharmaceutical Inc. 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | Increase | +72.49% | 145.86K shares | 2.36M | $41.41 | 347.08K |
| Q2 2022 | share | Decrease | -10.15% | -22.73K shares | -4.25M | $59.66 | 201.21K |
| Q1 2022 | share | Decrease | -5.00% | -11.79K shares | -3.56M | $72.62 | 223.95K |
| Q4 2021 | share | Increase | +20.20% | 39.62K shares | 2.13M | $84.25 | 235.74K |
| Q3 2021 | share | Decrease | -6.72% | -14.11K shares | -2.35M | $90.19 | 196.12K |
| Q2 2021 | share | Decrease | -7.94% | -18.12K shares | -5.95M | $95.35 | 210.24K |
| Q1 2021 | share | Increase | +0.66% | 1.49K shares | -5.40M | $113.86 | 228.36K |
| Q4 2020 | share | Increase | 0.00% | 226.87K shares | 31.40M | $138.43 | 226.87K |
| Q1 2017 | share | Decrease | -100.00% | -337.62K shares | -23.73M | $67.78 | 0 |
| Q4 2016 | share | Increase | +25.06% | 67.64K shares | 4.58M | $70.31 | 337.62K |
| Q3 2016 | share | Increase | 0.00% | 269.98K shares | 19.15M | $70.94 | 269.98K |